Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Menaquinone-7,Ankascin 568-R
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Approved
Sponsor : Gnosis by Lesaffre
Deal Size : Undisclosed
Deal Type : Partnership
SunWay Biotech and Gnosis Launch MenaQ7® Metabolic Featuring ANKASCIN® 568-R Ingredient
Details : The partnership aims to launch SunWay's inaugural product, MenaQ7® Metabolic, featuring two key active ingredients, MenaQ7® Vitamin K2 as MK-7 and ANKASCIN® 568-R.
Brand Name : MenaQ7
Molecule Type : Small molecule
Upfront Cash : Undisclosed
March 14, 2024
Lead Product(s) : Menaquinone-7,Ankascin 568-R
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Approved
Sponsor : Gnosis by Lesaffre
Deal Size : Undisclosed
Deal Type : Partnership
LOOKING FOR A SUPPLIER?